CMS (Centers for Medicare and Medicaid Services) says computer overhaul delayed diagnostics decision
This article was originally published in Clinica
Medicare's new national coverage rules for 23 common clinical diagnostic services is being pushed back from November 25 2002 to January 1 2003, according the Centers for Medicare and Medicaid Services (CMS).
You may also be interested in...
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.
Trade group also compiled website with information and resources to help members "stay up to date and take any necessary steps to mitigate the risks associated with COVID-19." Its members also got a chance to describe potential supply chain disruptions in survey for USDA.